Action plan for drug-resistant Streptococcus pneumoniae. The DRSP Working Group

MeSH terms

• Anti-Bacterial Agents / adverse effects
• Anti-Bacterial Agents / therapeutic use*
• Bacteremia / drug therapy
• Bacteremia / epidemiology
• Centers for Disease Control and Prevention, U.S. / organization & administration
• Drug Resistance, Microbial
• Humans
• Meningitis, Bacterial / drug therapy
• Meningitis, Bacterial / epidemiology
• Pneumococcal Infections / drug therapy*
• Pneumococcal Infections / epidemiology
• Pneumococcal Infections / prevention & control
• Pneumococcal Infections / transmission
• Pneumonia, Pneumococcal / drug therapy
• Pneumonia, Pneumococcal / epidemiology
• Population Surveillance
• Streptococcus pneumoniae / drug effects
• Streptococcus pneumoniae / immunology
• Streptococcus pneumoniae / pathogenicity
• United States
• Vaccination